Results 141 to 150 of about 39,514 (227)

Quality evaluation of online platforms information for retail of prescription medicines in China: an observational study of the case of paroxetine. [PDF]

BMC Med Inform Decis Mak
Yao H, Li C, Shi X, Peng B, Kang Z, Sun J, Liu Y.   +6 more
europepmc   +1 more source

Efficacy of Paroxetine as an Adjuvant Therapy in Rheumatoid Arthritis Patients: A Randomized Controlled Study. [PDF]

Drug Des Devel Ther
Aldossary KM, Abdallah MS, Mosalam EM, Kamal N, Saif DS, Elsayed SA, Afifi N, Zakaraia HG, Khrieba MO, Bahaa MM.   +9 more
europepmc   +1 more source

Case Report: A case of drug-induced pancreatitis caused by paroxetine with a literature review. [PDF]

Front Med (Lausanne)
Wu Y, Lv D, Liu L, Liu Y.
europepmc   +1 more source

Predicting drug-drug interactions between ayahuasca alkaloids and SSRIs using physiologically based pharmacokinetic modeling. [PDF]

Front Mol Biosci
Ribeiro GSG, Paranhos BAPB, Dörr F, Yonamine M, Villanova B, Guerra LTL, Raminelli AO, Reis JAS, de Paula CC, Zacharias ABV, Cecílio Hallak JE, Dos Santos RG, Martins FS, Marcourakis T.   +13 more
europepmc   +1 more source

Clinical Evaluation of Drug-Drug Interactions With Aficamten. [PDF]

Clin Transl Sci
Maharao N, Xu D, Divanji P, Simkins TJ, Li J, Dumitrescu C, Solanki P, Griffith A, Heitner SB, Kupfer S, German P, Lutz JD.   +11 more
europepmc   +1 more source

Repurposing the SSRI paroxetine increases lymphocyte mobilization and improves the efficacy of measles virus-based immunovirotherapy. [PDF]

Mol Ther Oncol
Stergiopoulos GM, Concilio SC, Viker KB, Clark SM, Robinson SI, Galanis E.   +5 more
europepmc   +1 more source

Oral paroxetine improves symptoms and quality of life in refractory irritable bowel syndrome: a retrospective study. [PDF]

Am J Transl Res
Wang Z, Xu H, Liu Z.
europepmc   +1 more source

Cardiac Valvular Incompetence Associated With Selective Serotonin Reuptake Inhibitors (SSRIs): A Disproportionality and Risk Factor Analysis From Global Safety Reports. [PDF]

Cureus
Chan ACY, Han Y.
europepmc   +1 more source

Explainable counterfactual reasoning in depression medication selection at multi-levels (personalized and population). [PDF]

BMC Med Inform Decis Mak
Qin X, Chignell MH, Greifenberger A, Lokuge S, Toumeh E, Sternat T, Katzman M, Wang L.   +7 more
europepmc   +1 more source

Leveraging developmental neurotoxicity data in zebrafish embryos through the use of artificial intelligence methods. [PDF]

Front Toxicol
Heusinkveld HJ, Hessel EVS, Zwart EP, Gremmer ER, Pennings JLA.   +4 more
europepmc   +1 more source